QPharma Inc.
QPharma Inc., a leading player in the pharmaceutical industry, is headquartered in the United States and operates across various regions, including North America and Europe. Founded in 2003, the company has established itself as a trusted provider of innovative solutions in drug development and regulatory affairs. Specialising in clinical trial management and pharmacovigilance, QPharma Inc. offers unique services that streamline the drug approval process, ensuring compliance with stringent regulatory standards. The company’s commitment to quality and efficiency has positioned it as a preferred partner for pharmaceutical and biotechnology firms. With a strong track record of successful project delivery and a focus on customer satisfaction, QPharma Inc. continues to achieve notable milestones, reinforcing its reputation as a key contributor to the advancement of healthcare solutions.
DitchCarbon Score
How does QPharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
QPharma Inc.'s score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
QPharma Inc.'s reported carbon emissions
QPharma Inc., headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that QPharma may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to establish clear targets for reducing greenhouse gas emissions across all scopes. As the industry evolves, it is anticipated that QPharma will develop and disclose its climate strategies and emissions data in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
QPharma Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
